Combination of Aflibercept and Bromfenac Therapy in Age-Related Macular Degeneration: A Pilot Study Aflibercept and Bromfenac in AMD

BACKGROUND: Among many protocols for treatment of exudative AMD, combined therapy of anti-VEGF agents and non-steroidal anti-inflammatory drugs (NSAIDs) seems to be an ideal alternative to monotherapy based on ranibizumab or bevacizumab. The aim of this study was to evaluate the effectiveness of afl...

Descripción completa

Detalles Bibliográficos
Autores principales: Wyględowska-Promieńska, Dorota, Piotrowska-Gwóźdź, Anna, Piotrowska-Seweryn, Agnieszka, Mazur-Piotrowska, Grażyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2015
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687982/
https://www.ncbi.nlm.nih.gov/pubmed/26667262
http://dx.doi.org/10.12659/MSM.895977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687982/
https://www.ncbi.nlm.nih.gov/pubmed/26667262
http://dx.doi.org/10.12659/MSM.895977

Ejemplares similares